 |
Resources for Incubator Tenants
The PBC recognizes that its role assisting biotechnology start-up companies achieve success does not end in the lab. To that end, the PBC has arranged for its incubator companies to have access to experts in the fields listed below, thus helping ensure the future viability of these important business ventures.
Biotechnology and Nanotechnology
Entrepreneurial Consultant - Ronald C. Gamble, Ph.D.
Consultant, Gamble and Associates Ltd., LLC, Pasadena
rcgamble1@earthlink.net
With a background in chemistry, Dr. Gamble has been involved with local entrepreneurial activities in both biotechnology and nanotechnology (Nanostream, JPL, Vestar ) and has research experience with many areas of high technology and high throughput.John Petrovich
Labyrinth Strategic Business Guidance
john@labyrinthstrategic.com
John Petrovich offers strategic and tactical advice to private and public companies as a corporate finance attorney and serial entrepreneur/executive. He has served as CEO of two startups (Calando Pharmaceuticals and Insert Therapeutics) and advised others (VasGene) in developing therapeutics from startup through Phase I clinical trials.
Bioinformatics, Data Management
Consultant - Richard Johnston, M.S. (UCLA)
rmjohnston@mac.com
Mr. Johnston teaches the Bioinformatics (Biology 28) course at Pasadena City College, runs Data Management workshops (Excel in the Lab), and has consulting contracts with several local research groups.
Business Plan Development
Consultant - Carolyn Siegal, MS, Public Health (UCLA)
CEO, Siegal Consulting
csiegal@siegalconsulting.com • www.siegalconsulting.com
Carolyn Siegal is a business development and new product marketing consultant for the biotechnology industry. She currently serves as a principal advisor to the NIH Commercialization Access Program for SBIR grant recipients. Ms. Siegal has worked with numerous biotechnology companies in evaluating new products, crafting business plans and establishing strategic alliances. She has over two decades of industry experience including executive positions at Xencor, Cell-Matrix and Alpha Therapeutic Corporation.
Cell Culture, Stem Cell Culture and Molecular Biology
Consultant - Pam Eversole-Cire, Ph.D. (USC)
eversole@caltech.edu
Dr. Eversole-Cire completed her postdoctoral studies at Caltech in Dr. Mel Simon's Laboratory Group. She currently directs the Biological Technology Program at Pasadena City College.
Conference Facilities
Peter Moglia
Alexandria Real Estate Equities
Tel: 626-578-9693
Mr. Moglia has offered the use of the conference facilities of the Alexandria Innovation Center (129 N. Hill Avenue, Pasadena) for any of the PBC's tenants wishing to host a business meeting. Contact Peter to reserve the space ahead of time.
Finance
CPA Assistance - John Wright, CPA (MBA Stanford)
wrightjrjr@aol.com
John Wright has served as CFO for several area startups. A Senior Financial Executive with experience spanning manufacturing, leasing, technical services, management consulting, and international business, Mr. Wright's responsibilities have included information services, risk management, procurement, tax planning, pricing, merger/acquisition studies, activity-based costing, and internal audit.CPA Assistance - James Schaefer, CPA, MBA, Managing Partner
Mark Schaefer Associates LLP
jschaefer@msaconsult.com
James Schaefer has primary responsibility for consulting on financial issues including business plans, financial projections, business valuations, mergers and acquisitions and management information systems. Mr. Schaefer's special emphasis is in business strategies for revenue enhancement, cost control and financial management.
Grant Writing, SBIR
James Kilgore, Ph.D.
jlkbiorg@charter.net
Working in R&D in the biotech and pharmaceutical industries, Dr. Kilgore has been awarded over $ 1 million in SBIR grants from NIH as PI.
Legal
Corporate Attorney - Richard Jones
Nixon Peabody LLP
rjones@nixonpeabody.com
Rick Jones has a long association with the PBC, and joined Nixon Peabody’s Public Finance Team after serving in the Transactions Department of O’Melveny & Myers LLP. He has extensive experience in both tax-exempt and taxable government financings, having practiced in the public finance area since 1977. He has acted as bond counsel for many California state and local agencies and as underwriter’s counsel, borrower’s counsel, and liquidity/credit provider’s counsel in a wide range of transactions. Mr. Jones also has experience in mergers and acquisitions and in corporate equity financings.Patent Attorney - John W. Peck, Ph.D.
Associate, Christie, Parker and Hale, LLP
john.peck@cph.com • Tel: 949-476-0757 • Fax: 949-476-8640
Dr. Peck has a Ph.D. in Chemistry from USC and received his law degree from New York University School of Law in 2000.Patent Attorney - Jeff Sheldon
Sheldon Mak Rose & Anderson PC
JGSheldon@usip.com • www.usip.com/resumes/sheldon.htm
Jeff Sheldon's technical background is in biomedical and chemical engineering. He was previously employed as a chemical engineer by Exxon and Shell Chemical, as a scientific coordinator by Lee Pharmaceutical and as a medical device development engineer by American Hospital Supply Corporation. Jeff Sheldon practices the full range of intellectual property including prosecution, litigation, and international and domestic licensing.
Marketing Plan Development
Consultant - Dave Skibinski, B.S. Biology, MBA
CEO, Quantum Method
dave@quantummethod.com • www.quantummethod.com
Dave Skibinski has 20 years experience in the life science industry (pharmaceuticals, biologicals, medical devices, nutraceuticals and industry enabling technologies) including therapeutic categories such as cardiology, infectious disease, gynecology, surgery, rheumatology and pediatrics. Mr. Skibinski's capabilities include: feasibility studies, business and marketing plan development, marketing communication, corporate and product identity creation, website and other digital media, advertising and marketing collateral, and trade show design. Mr. Skibinski worked for GlaxoSmithKline and Dendrite International. He holds a B.S. Biology from Indiana University and a MBA from USC.